Modelling the cost-effectiveness of adopting risk-stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland. (Q39867113)

From Wikidata

Jump to navigation Jump to search

scientific article published on 4 April 2016

Language	Label	Description	Also known as
English	Modelling the cost-effectiveness of adopting risk-stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland.	scientific article published on 4 April 2016

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27040994%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Modelling the cost-effectiveness of adopting risk-stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27040994%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27040994%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27040994%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Helen M. Colhoun

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27040994%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Mehdi Javanbakht

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27040994%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

author name string

G Scotland

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27040994%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

G P Leese

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27040994%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

J A Olson

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27040994%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

H C Looker

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27040994%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

11 May 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27040994%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Diabetic Medicine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27040994%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

33

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27040994%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

886-895

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27040994%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27040994%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Should diabetes retinal screening intervals change?

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

Extending the diabetic retinopathy screening interval beyond 1 year: systematic review

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

External quality assurance for image grading in the Scottish Diabetic Retinopathy Screening Programme.

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: a prospective, multicentre, UK study

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform.

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

What is the cost of blindness?

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

Health utility values associated with diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

The efficacy of automated "disease/no disease" grading for diabetic retinopathy in a systematic screening programme

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

Cost-effectiveness of implementing automated grading within the national screening programme for diabetic retinopathy in Scotland

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: an indirect comparison in a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

Progression of diabetes retinal status within community screening programs and potential implications for screening intervals.

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

Economic evaluation of screening for diabetic retinopathy among Chinese type 2 diabetics: a community-based study in Kinmen, Taiwan

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

The evaluation of screening policies for diabetic retinopathy using simulation.

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening

1 reference

https://api.crossref.org/works/10.1111%2FDME.13129

21 January 2018

Identifiers

10.1111/DME.13129

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27040994%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27040994%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39867113&oldid=2091753904"